My Companies
Notification
Account
Log Out
Login
Orchid Pharma signed a licensing and supply agreement with Pharmasyntez JSC to commercialize Exblifep in Russia, with a potential opportunity of approximately USD 178 million over the first 10 years.
No events have occurred recently